| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-12 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-10 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-10 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-10 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.2 | 8e-09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-08 |